We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXG icon
426
MiMedx Group
MDXG
$622M
$424K 0.08%
+55,117
New +$443K
MFA
427
MFA Financial
MFA
$919M
$424K 0.08%
+37,167
New +$416K
BMY icon
428
Bristol-Myers Squibb
BMY
$132B
$424K 0.08%
7,811
-5,093
-39% -$259K
NMIH icon
429
NMI Holdings
NMIH
$3.32B
$422K 0.08%
+13,047
New +$394K
CFG icon
430
Citizens Financial Group
CFG
$30.6B
$422K 0.08%
11,621
+3,674
+46% +$121K
RWT
431
Redwood Trust
RWT
$574M
$422K 0.08%
+66,171
New +$432K
ATNI icon
432
ATN International
ATNI
$494M
$421K 0.08%
+13,369
New +$467K
COMP icon
433
Compass
COMP
$9.52B
$419K 0.08%
+116,351
New +$411K
STR
434
DELISTED
Sitio Royalties
STR
$416K 0.08%
+16,844
New +$379K
RMNI icon
435
Rimini Street
RMNI
$458M
$415K 0.08%
127,159
+116,814
+1,129% +$373K
C icon
436
Citigroup
C
$227B
$412K 0.08%
6,507
-4,088
-39% -$227K
XPER icon
437
Xperi
XPER
$332M
$411K 0.08%
+34,099
New +$375K
BHE icon
438
Benchmark Electronics
BHE
$2.92B
$408K 0.08%
13,610
+5,467
+67% +$158K
LSXMA
439
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$408K 0.08%
13,751
+1,639
+14% +$49.3K
BMRN icon
440
BioMarin Pharmaceuticals
BMRN
$13.3B
$408K 0.08%
+4,668
New +$418K
HHH icon
441
Howard Hughes
HHH
$3.91B
$407K 0.08%
+5,881
New +$436K
DXC icon
442
DXC Technology
DXC
$1.74B
$401K 0.08%
18,899
+1,641
+10% +$35.8K
BCRX icon
443
BioCryst Pharmaceuticals
BCRX
$2.51B
$400K 0.08%
78,814
+66,051
+518% +$371K
DK icon
444
Delek US
DK
$3.72B
$399K 0.08%
+12,996
New +$352K
HUBG icon
445
HUB Group
HUBG
$2.9B
$399K 0.08%
+9,236
New +$404K
YELP icon
446
Yelp
YELP
$1.35B
$398K 0.08%
+10,108
New +$419K
MKC icon
447
McCormick & Company Non-Voting
MKC
$14.3B
$395K 0.08%
+5,148
New +$350K
RGP icon
448
Resources Connection
RGP
$145M
$395K 0.08%
+30,034
New +$401K
KRO icon
449
KRONOS Worldwide
KRO
$977M
$395K 0.08%
+33,435
New +$324K
EVRG icon
450
Evergy
EVRG
$18.9B
$394K 0.08%
+7,386
New +$377K
16 17
18
19 20

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.